{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:56:59Z","timestamp":1793386619393,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001858","name":"Sweden's Innovation Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009769","name":"Mats Klebergs Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009768","name":"May Flower National Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009768","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.jcf.2025.03.670","type":"journal-article","created":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T15:26:09Z","timestamp":1744989969000},"page":"704-709","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Remote monitoring of cystic fibrosis lung disease in children and young adults"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0194-7365","authenticated-orcid":false,"given":"Marcus","family":"Svedberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Michelsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huda Abdulahi","family":"Ostrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9705-0335","authenticated-orcid":false,"given":"Christine","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Krantz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petrea","family":"Ericsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrika","family":"Lindberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9447-663X","authenticated-orcid":false,"given":"Henrik","family":"Imberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.jcf.2025.03.670_bib0001","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1908639","article-title":"Elexacaftor-Tezacaftor-Ivacaftor for Cystic fibrosis with a single Phe508del Allele","volume":"381","author":"Middleton","year":"2019","journal-title":"N Engl J Med"},{"issue":"10212","key":"10.1016\/j.jcf.2025.03.670_bib0002","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/S0140-6736(19)32597-8","article-title":"Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial","volume":"394","author":"Heijerman","year":"2019","journal-title":"Lancet"},{"issue":"21","key":"10.1016\/j.jcf.2025.03.670_bib0003","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1056\/NEJMoa0909825","article-title":"Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation","volume":"363","author":"Accurso","year":"2010","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.jcf.2025.03.670_bib0004","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02029-2022","article-title":"Long-term safety and efficacy of elexacaftor\/tezacaftor\/ivacaftor in people with cystic fibrosis and at least one F508del allele: 144-week interim results from a 192-week open-label extension study","volume":"62","author":"Daines","year":"2023","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcf.2025.03.670_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcf.2024.09.011","article-title":"Cystic fibrosis foundation position paper: redefining the cystic fibrosis care team","author":"Brown","year":"2024","journal-title":"J Cyst Fibros"},{"issue":"1","key":"10.1016\/j.jcf.2025.03.670_bib0006","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jcf.2023.12.002","article-title":"Standards for the care of people with cystic fibrosis; establishing and maintaining health","volume":"23","author":"Southern","year":"2024","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2025.03.670_bib0007","first-page":"23","article-title":"Telemedicine and cystic fibrosis: do we still need face-to-face clinics?","volume":"42","author":"Dixon","year":"2022","journal-title":"Paediatr Respir Rev"},{"issue":"6","key":"10.1016\/j.jcf.2025.03.670_bib0008","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/MCP.0000000000000821","article-title":"Telehealth and virtual health monitoring in cystic fibrosis","volume":"27","author":"Vagg","year":"2021","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.jcf.2025.03.670_bib0009","doi-asserted-by":"crossref","DOI":"10.1002\/ppul.27166","article-title":"Telemedicine and home spirometry in cystic fibrosis: A prospective multicenter study","author":"Medbo","year":"2024","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2025.03.670_bib0010","article-title":"Education and implementation of home spirometry in an adolescent cystic fibrosis population","volume":"84","author":"Schaffer","year":"2023","journal-title":"Respir Med Res"},{"issue":"1","key":"10.1016\/j.jcf.2025.03.670_bib0011","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jcf.2021.08.013","article-title":"A comparison of clinic and home spirometry as longtudinal outcomes in cystic fibrosis","volume":"21","author":"Paynter","year":"2022","journal-title":"J Cyst Fibros"},{"issue":"10","key":"10.1016\/j.jcf.2025.03.670_bib0012","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1002\/ppul.26602","article-title":"Unsupervised home spirometry is not equivalent to supervised clinic spirometry in children and young people with cystic fibrosis: results from the CLIMB-CF study","volume":"58","author":"Edmondson","year":"2023","journal-title":"Pediatr Pulmonol"},{"issue":"169","key":"10.1016\/j.jcf.2025.03.670_bib0013","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0248-2022","article-title":"Unsupervised home spirometry versus supervised clinic spirometry for respiratory disease: a systematic methodology review and meta-analysis","volume":"32","author":"Anand","year":"2023","journal-title":"Eur Respir Rev"},{"issue":"4","key":"10.1016\/j.jcf.2025.03.670_bib0014","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/17476348.2023.2202852","article-title":"Outpatient management of pulmonary exacerbations in children with cystic fibrosis","volume":"17","author":"Perrem","year":"2023","journal-title":"Expert Rev Respir Med"},{"issue":"5","key":"10.1016\/j.jcf.2025.03.670_bib0015","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.jcf.2023.06.015","article-title":"Factors associated with lung function response with oral antibiotic treatment of pulmonary exacerbations in cystic fibrosis","volume":"22","author":"Blanchard","year":"2023","journal-title":"J Cyst Fibros"},{"issue":"9","key":"10.1016\/j.jcf.2025.03.670_bib0016","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1164\/rccm.201610-2172OC","article-title":"Home monitoring of patients with cystic fibrosis to identify and treat acute pulmonary exacerbations. EICE study results","volume":"196","author":"Lechtzin","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"10.1016\/j.jcf.2025.03.670_bib0017","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1164\/rccm.201908-1590ST","article-title":"Standardization of Spirometry 2019 update. An official American Thoracic Society and European Respiratory Society technical statement","volume":"200","author":"Graham","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.jcf.2025.03.670_bib0018","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jcf.2018.02.006","article-title":"ECFS best practice guidelines: the 2018 revision","volume":"17","author":"Castellani","year":"2018","journal-title":"J Cyst Fibros"},{"issue":"6","key":"10.1016\/j.jcf.2025.03.670_bib0019","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1183\/09031936.00080312","article-title":"Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations","volume":"40","author":"Quanjer","year":"2012","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.jcf.2025.03.670_bib0020","doi-asserted-by":"crossref","DOI":"10.2196\/11080","article-title":"Clinical adoption of mHealth technology to support pediatric cystic fibrosis care in Sweden: qualitative case study","volume":"1","author":"Longacre","year":"2018","journal-title":"JMIR Pediatr Parent"},{"issue":"5","key":"10.1016\/j.jcf.2025.03.670_bib0021","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.jcf.2023.04.009","article-title":"Mobile health platform for self-management of pediatric cystic fibrosis: impact on patient-centered care outcomes","volume":"22","author":"Oates","year":"2023","journal-title":"J Cyst Fibros"},{"issue":"6","key":"10.1016\/j.jcf.2025.03.670_bib0022","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/00063198-199811000-00003","article-title":"Measurement of quality of life in cystic fibrosis","volume":"4","author":"Quittner","year":"1998","journal-title":"Curr Opin Pulm Med"},{"issue":"2","key":"10.1016\/j.jcf.2025.03.670_bib0023","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1183\/09031936.05.00034805","article-title":"Standardisation of spirometry","volume":"26","author":"Miller","year":"2005","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.jcf.2025.03.670_bib0024","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.jcf.2024.07.005","article-title":"Impact of day-to-day variation in FEV1 on measures of change: A conceptual description","volume":"23","author":"Magaret","year":"2024","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2025.03.670_bib0025","article-title":"Risk factors for progression of structural lung disease in school-age children with cystic fibrosis","author":"Svedberg","year":"2019","journal-title":"J Cyst Fibros"},{"issue":"10","key":"10.1016\/j.jcf.2025.03.670_bib0026","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1136\/thoraxjnl-2011-200953","article-title":"Understanding the natural progression in %FEV1 decline in patients with cystic fibrosis: a longitudinal study","volume":"67","author":"Taylor-Robinson","year":"2012","journal-title":"Thorax"},{"key":"10.1016\/j.jcf.2025.03.670_bib0027","doi-asserted-by":"crossref","first-page":"j4574","DOI":"10.1136\/bmj.j4574","article-title":"Diagnosis and management of cystic fibrosis: summary of NICE guidance","volume":"359","author":"Villanueva","year":"2017","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.jcf.2025.03.670_bib0028","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jcf.2023.05.011","article-title":"Quantifying variation in home spirometry in people with cystic fibrosis during baseline health, and associations with clinical outcomes","volume":"23","author":"Thornton","year":"2024","journal-title":"J Cyst Fibros"},{"issue":"6","key":"10.1016\/j.jcf.2025.03.670_bib0029","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.jcf.2024.08.007","article-title":"Cystic fibrosis foundation position paper: redefining the CF care model","volume":"23","author":"Goetz","year":"2024","journal-title":"J Cyst Fibros"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199325007660?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199325007660?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T05:16:19Z","timestamp":1778822179000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199325007660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S1569199325007660"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2025.03.670","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Remote monitoring of cystic fibrosis lung disease in children and young adults","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2025.03.670","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of European Cystic Fibrosis Society.","name":"copyright","label":"Copyright"}]}}